• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Risk of myopathy and myalgia among statin users may be small and clinically insignificant

byNeel MistryandTeddy Guo
September 20, 2022
in Cardiology, Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. 27.1% of patient in the statin group reported muscle pain and weakness compared to 26.6% in the control groups.

2. Risk of symptoms appeared to be more common among patients in the higher dose statin group.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Statins are lipid lowering agents that decrease the risk of cardiovascular disease through inhibition of the HMG-CoA reductase enzyme. Well-known, but rare, side effects of statins include myopathy and myalgia. However, whether these symptoms occur because of the statin itself is controversial. This meta-analysis aimed to assess the effect of statin therapy on muscle pain and weakness using evidence from 19 placebo-controlled randomized trials. The primary outcome was the incidence of statin-related myalgia at one year, while key secondary outcomes included excess muscle pain and weakness as well as rise in creatine kinase. According to study results, patients in the statin group reported an increase in mild muscle pain, although this was not due to the statin. Furthermore, most reported cases of muscle pain or weakness occurred in the first year and did not lead to treatment discontinuation since they were deemed to be clinically mild. This study was strengthened by the accumulation of data from several large, well-conducted, randomized trials, thus adding to its validity.

Click to read the study in The Lancet

Relevant Reading: 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

In-depth [meta-analysis]: This study comprised of patients from 19 double-blind trials of statin versus placebo (n=123 940) and 4 double-blind trials of more intensive versus less intensive statin regimen (n=30 724) between 1994 and 2016. Included were trials with ≥ 1000 patients who were on statin therapy for ≥ 2 years. Among placebo-controlled trials, mean age of patients was 63 years (standard deviation [SD] 8) and 48.1% (n=59 610) had previous vascular disease. The primary outcome of myalgia and myopathy was marginally greater in the statin therapy group (n=16 835, 27.1%) compared to placebo (n=16 446, 26.6%; rate ratio [RR] 1.03, 95% confidence interval [CI] 1.01-1.06). A dose-dependent effect was seen as more intensive regimen versus placebo resulted in more symptoms (RR 1.08, 95% CI 1.04-1.13) compared to less intensive therapy versus placebo (RR 1.03, 1.00-1.05). In the first year of statin therapy, there was a 7% relative increase in muscle pain and weakness (RR 1.07, 1.04-1.10); however, after year one, the excess muscle pain attributed to statin use was not seen (RR 0.99, 0.96-1.02) Statin therapy mildly increased creatine kinase levels. Overall, findings from this study suggest that while statins may increase the likelihood of myalgia and myopathy, this does not appear to be treatment related. Furthermore, the cardiovascular benefits of statins far outweigh their risks.

RELATED REPORTS

Left atrial reservoir strain improves ischemic stroke risk prediction in low-risk patients

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

Team-based care with a clinical decision support system reduces cardiovascular risk factors in diabetic patients

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: atherosclerosisAtorvastatincardiovascular diseasecholesteroldyslipidemiaLDL cholesterolmuscle weaknessmyalgiamyocardial infarctionmyopathyrosuvastatinsimvastatinstatinstatin therapystroke
Previous Post

Parental input in oncology-related palliation and pain relief for children [Classics Series]

Next Post

Impact on socioeconomic status with HFrEF outcomes

RelatedReports

Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Cardiology

Left atrial reservoir strain improves ischemic stroke risk prediction in low-risk patients

January 31, 2023
Preterm birth associated with cardiovascular risk factors in adolescence
Cardiology

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

January 4, 2023
Higher parental monitoring linked to safer sex in teens
Cardiology

Team-based care with a clinical decision support system reduces cardiovascular risk factors in diabetic patients

December 22, 2022
Population-based risk factors and geographical trends identified for vitiligo
Cardiology

The majority of FDA-approved drug trials recruit from low- and middle-income countries

December 9, 2022
Next Post
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Impact on socioeconomic status with HFrEF outcomes

Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse

Sleep disorders are risk factors in the onset of depression

Disparities in type 1 diabetes not explained by socioeconomic status alone

Neighborhood disadvantage is associated with increased risk of psychiatric disorders in refugee children

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Rocatinlimab may be effective in the treatment of moderate-to-severe atopic dermatitis
  • Gender-affirming hormones improve psychosocial functioning in transgender youth
  • Left atrial reservoir strain improves ischemic stroke risk prediction in low-risk patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options